Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Review

Who needs to carry an epinephrine autoinjector?

T. Ted Song, DO, FAAAI, FACP and Phil Lieberman, MD
Cleveland Clinic Journal of Medicine January 2019, 86 (1) 66-72; DOI: https://doi.org/10.3949/ccjm.86a.17123
T. Ted Song
Clinical Associate Professor of Medicine, Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Phil Lieberman
Department of Medicine and Pediatrics, University of Tennessee College of Medicine, Memphis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Patients who have had anaphylaxis or who are at risk of it (eg, due to food allergy or Hymenoptera hypersensitivity) should carry an epinephrine autoinjector at all times. However, the risks and benefits must be considered on an individual basis, especially in patients with athero-sclerotic heart disease, elderly patients on polypharmacy, patients receiving allergen immunotherapy, those with large local reactions to insect stings, and individuals with oral allergy syndrome.

Footnotes

  • Dr. Song has disclosed membership on advisory committees or review panels for Allergopharma, and teaching and speaking for Novartis and Teva. Dr. Lieberman has disclosed consulting for Kaléo.

  • Copyright © 2019 The Cleveland Clinic Foundation. All Rights Reserved.
View Full Text
  1. T. Ted Song, DO, FAAAI, FACP⇑
  1. Clinical Associate Professor of Medicine, Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle
  1. ADDRESS:
    T. Ted Song, DO, Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, 1203 Bridgeport Way SW, Lakewood, WA 98499; tsong{at}allergyasthmass.com
  1. Phil Lieberman, MD
  1. Department of Medicine and Pediatrics, University of Tennessee College of Medicine, Memphis

ABSTRACT

Patients who have had anaphylaxis or who are at risk of it (eg, due to food allergy or Hymenoptera hypersensitivity) should carry an epinephrine autoinjector at all times. However, the risks and benefits must be considered on an individual basis, especially in patients with athero-sclerotic heart disease, elderly patients on polypharmacy, patients receiving allergen immunotherapy, those with large local reactions to insect stings, and individuals with oral allergy syndrome.

Footnotes

  • Dr. Song has disclosed membership on advisory committees or review panels for Allergopharma, and teaching and speaking for Novartis and Teva. Dr. Lieberman has disclosed consulting for Kaléo.

  • Copyright © 2019 The Cleveland Clinic Foundation. All Rights Reserved.
View Full Text
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 86 (1)
Cleveland Clinic Journal of Medicine
Vol. 86, Issue 1
1 Jan 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Who needs to carry an epinephrine autoinjector?
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Who needs to carry an epinephrine autoinjector?
T. Ted Song, Phil Lieberman
Cleveland Clinic Journal of Medicine Jan 2019, 86 (1) 66-72; DOI: 10.3949/ccjm.86a.17123

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Who needs to carry an epinephrine autoinjector?
T. Ted Song, Phil Lieberman
Cleveland Clinic Journal of Medicine Jan 2019, 86 (1) 66-72; DOI: 10.3949/ccjm.86a.17123
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • ABSTRACT
    • EPINEPHRINE IS THE TREATMENT OF CHOICE FOR ANAPHYLAXIS
    • WHO SHOULD CARRY AN EPINEPHRINE AUTOINJECTOR?
    • PATIENTS FOR WHOM THE NEED MAY BE LESS CLEAR
    • CAUTIONS, NOT CONTRAINDICATIONS
    • INJECTOR OPTIONS
    • BARRIERS TO USING EPINEPHRINE AUTOINJECTORS
    • NEED FOR PATIENT EDUCATION
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Alpha-gal syndrome: Recognizing and managing a tick-bite–related meat allergy
  • Managing right ventricular failure in the setting of pulmonary embolism
  • Psychedelics, spirituality, and existential distress in patients at the end of life
Show more Review

Similar Articles

Subjects

  • Allergy/Immunology
  • Drug Therapy
  • Emergency Medicine

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire